RJA
NTUS

Raymond James & Associates’s Natus Medical Inc NTUS Stock Holding History

Raymond James & Associates’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,888
Closed -$711K – 3747
2018
Q4 		$711K Sell
20,888
-1,165
-5% -$37.9K ﹤0.01% 2304
2018
Q3 		$786K Sell
22,053
-343
-2% -$12.1K ﹤0.01% 2413
2018
Q2 		$773K Buy
22,396
+6,644
+42% +$233K ﹤0.01% 2372
2018
Q1 		$530K Buy
+15,752
New +$499K ﹤0.01% 2532
2017
Q1 		– Sell
-25,370
Closed -$883K – 3431
2016
Q4 		$883K Buy
25,370
+5,015
+25% +$197K ﹤0.01% 1988
2016
Q3 		$800K Buy
20,355
+5,455
+37% +$218K ﹤0.01% 2008
2016
Q2 		$563K Buy
14,900
+367
+3% +$12.3K ﹤0.01% 2047
2016
Q1 		$559K Sell
14,533
-7,649
-34% -$285K ﹤0.01% 1989
2015
Q4 		$1.07M Buy
22,182
+4,412
+25% +$204K ﹤0.01% 1597
2015
Q3 		$701K Sell
17,770
-8,105
-31% -$344K ﹤0.01% 1776
2015
Q2 		$1.1M Buy
25,875
+8,722
+51% +$348K ﹤0.01% 1681
2015
Q1 		$677K Buy
+17,153
New +$633K ﹤0.01% 1886

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Raymond James & Associates's NTUS Position: Q1 2019 in Review

Raymond James & Associates sold out of Natus Medical Inc (NTUS) in Q1 2019, closing a stake of 20,888 shares — an estimated $711K sold.

Raymond James & Associates first reported a position in NTUS in Q1 2015 and held it in 12 quarters. The position peaked at $1.1M in Q2 2015. 168 funds tracked by Wall St. Rank hold NTUS as of Q1 2019.

  • Raymond James & Associates reported no remaining Natus Medical Inc position as of Q1 2019 after selling out during the quarter.
  • Raymond James & Associates sold 20,888 Natus Medical Inc shares in Q1 2019, an estimated $711K.
  • Raymond James & Associates first reported a position in Natus Medical Inc in Q1 2015 and held it in 12 quarters.
  • Raymond James & Associates's Natus Medical Inc position peaked at $1.1M in Q2 2015.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2019.

Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.